Comparative safety and immunogenicity of yeast recombinant hepatitis B vaccines containing S and pre-S2 + S antigens
- 1 May 1991
- Vol. 9 (5) , 346-350
- https://doi.org/10.1016/0264-410x(91)90062-b
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Anti‐PreS2 antibody assay for evaluating immune responses among recipients of recombinant hepatitis B PreS2+S vaccineJournal of Medical Virology, 1990
- Clinical experience with hepatitis B vaccinesAmerican Journal of Infection Control, 1989
- Protective effect of a synthetic peptide comprising the complete pres2 region of the hepatitis b virus surface proteinJournal of Medical Virology, 1989
- Production and immunological analysis of recombinant hepatitis B vaccineJournal of Infection, 1986
- Long-Term Immunogenicity and Efficacy of Hepatitis B Vaccine in Homosexual MenNew England Journal of Medicine, 1986
- Antibodies to a synthetic peptide from the preS 120–145 region of the hepatitis B virus envelope are virus-neutralizingVaccine, 1986
- The hepatitis B virusNature, 1985
- Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant DNAPublished by American Medical Association (AMA) ,1984
- Hepatitis B Vaccine in Medical Staff of Hemodialysis UnitsNew England Journal of Medicine, 1982
- Hepatitis B VaccineNew England Journal of Medicine, 1980